This area of our website is for healthcare professionals only

Please click below to declare your professional status:

YES, I am a healthcare professional  NO, I am not a healthcare professional

Guidelines and policies

Association of triglyceride lowering LPL variants and LDL-C lowering LDLR variants with risk of coronary heart disease Ference, M., Kastelein, J., Ray, K et al (2019)
Source: JAMA. 321. 4. 364-373

Low density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic and clinical studies.  A consensus statement from the European Atherosclerosis Society Panel
Source: European Heart Journal 

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study
Source: The Lancet

Joint British Societies for the Prevention of Cardiovascular Disease (2014) Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) 
Source: JBS3

National Institute for Health and Care Excellence (2014) Cardiovascular disease: risk assessment and reduction, including lipid modification
Source: NICE

Scottish Intercollegiate Guidelines Network (SIGN) Risk estimation and the prevention of cardiovascular disease.
Source: SIGN

Public Health England (2014) Adult obesity and type 2 diabetes.
Source: PHE